Market Overview:
The global sterility indicators market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for sterility indicators from hospitals, pharmaceutical companies, medical device companies, and clinical laboratories. Additionally, the growing awareness about sterilization and disinfection among consumers is also contributing to the growth of this market. The global sterility indicators market can be segmented on the basis of type into chemical indicators and biological indicators. The chemical indicator segment is expected to dominate the global sterility indicator market during the forecast period owing to its low cost and easy availability. However, with increasing concerns about environmental pollution, there is a growing demand for biological indicators in developed countries such as North America and Europe. On the basis of application, hospitals are expected to account for majority share of revenue in 2018 followed by pharmaceutical companies, medical device companies clinical laboratories.,and other applications respectively duringthe forecast period .This can be attributedto th efact that hospitals are required toreceive certificationfrom regulatory authorities such as Joint Commission International (JCI) or National Healthcare Association (NHA)for quality care services providedto patients .
Product Definition:
A sterility indicator is a device or material that provides a visible or physical indication of the sterility of an item or environment. The use of sterility indicators is important because it helps ensure that items and environments are sterile prior to use.
Chemical Indicators:
Chemical indicators are substances that change their physical properties when exposed to microorganisms. The most common ones used in medical sterilization procedures include methyl orange and ethyl yellow. These indicators change color when they come into contact with microorganisms, thus making them useful for detecting the presence of these pathogens in various products or samples.
Biological Indicators:
Biological indicators are used for monitoring the process of sterilization and also to check the effectiveness of sterilization. Biological indicators are living organisms that change physically or genetically in response to a stimulus, which is used as an indicator for determining whether a particular process or treatment has been effective in killing all microorganisms.
Escherichia coli (E.
Application Insights:
The other application segment includes food and waterborne pathogens, bio-contamination, and others. Sterility indicators are used in the manufacturing of medical devices & pharmaceuticals to sterilize surgical instruments, pharmaceutical products, drug packaging materials and even patient preparation materials. The use of these indicators helps ensure that all surfaces are sterile after use which prevents the contamination from other surfaces or hands.
Hospitals were the largest application segment for sterility Indicators market in 2017 owing to increasing investments by governments as well as private organizations to develop healthcare infrastructure at global level with better standards of care while reducing costs is a key factor driving this industry growth over next few years. Increasing prevalence of chronic diseases such as cancer along with rising number of surgeries has led to an increased demand for advanced sterilization techniques which is expected to drive this market growth over forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to various factors such as increasing awareness among people regarding hygiene and safety, stringent government regulations for sterilization and disinfection of medical equipment & devices, presence of well-established healthcare infrastructure, high purchasing power parity (PPP) of consumers, and rising demand for advanced medical products with reduced side effects.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving economic conditions in emerging countries like India & China which has led them being more open towards new technologies including pharmaceuticals & biotechnology sectors resulting in increased investments by major multinational companies resulting in greater product penetration ultimately driving growth across this region.
Growth Factors:
- Increasing demand for sterile products and devices
- Rising prevalence of hospital-acquired infections (HAIs)
- Growing number of surgical procedures worldwide
- Proliferation of medical tourism industry
- Technological advancements in sterilization methods
Scope Of The Report
Report Attributes
Report Details
Report Title
Sterility Indicators Market Research Report
By Type
Chemical Indicators, Biological Indicators
By Application
Hospitals, Pharmaceutical Companies, Medical Device Companies, Clinical laboratories, Other
By Companies
3M Company, Anderson Products Inc, Cantel Medical Corporation, Cardinal Health Inc, Getinge AB, Matachana Group, Mesa Laboratories, 3M Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Sterility Indicators Market Report Segments:
The global Sterility Indicators market is segmented on the basis of:
Types
Chemical Indicators, Biological Indicators
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Pharmaceutical Companies, Medical Device Companies, Clinical laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Company
- Anderson Products Inc
- Cantel Medical Corporation
- Cardinal Health Inc
- Getinge AB
- Matachana Group
- Mesa Laboratories
- 3M Company
Highlights of The Sterility Indicators Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemical Indicators
- Biological Indicators
- By Application:
- Hospitals
- Pharmaceutical Companies
- Medical Device Companies
- Clinical laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sterility Indicators Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sterility indicators are laboratory tests that can help doctors determine whether a woman is likely to become pregnant. Sterility indicators may include tests for sperm count, semen analysis, and cervical mucus.
Some of the key players operating in the sterility indicators market are 3M Company, Anderson Products Inc, Cantel Medical Corporation, Cardinal Health Inc, Getinge AB, Matachana Group, Mesa Laboratories, 3M Company.
The sterility indicators market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sterility Indicators Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sterility Indicators Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sterility Indicators Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sterility Indicators Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sterility Indicators Market Size & Forecast, 2018-2028
4.5.1 Sterility Indicators Market Size and Y-o-Y Growth
4.5.2 Sterility Indicators Market Absolute $ Opportunity
Chapter 5 Global Sterility Indicators Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sterility Indicators Market Size Forecast by Type
5.2.1 Chemical Indicators
5.2.2 Biological Indicators
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sterility Indicators Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sterility Indicators Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Pharmaceutical Companies
6.2.3 Medical Device Companies
6.2.4 Clinical laboratories
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sterility Indicators Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sterility Indicators Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sterility Indicators Analysis and Forecast
9.1 Introduction
9.2 North America Sterility Indicators Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sterility Indicators Market Size Forecast by Type
9.6.1 Chemical Indicators
9.6.2 Biological Indicators
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sterility Indicators Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Pharmaceutical Companies
9.10.3 Medical Device Companies
9.10.4 Clinical laboratories
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sterility Indicators Analysis and Forecast
10.1 Introduction
10.2 Europe Sterility Indicators Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sterility Indicators Market Size Forecast by Type
10.6.1 Chemical Indicators
10.6.2 Biological Indicators
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sterility Indicators Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Pharmaceutical Companies
10.10.3 Medical Device Companies
10.10.4 Clinical laboratories
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sterility Indicators Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sterility Indicators Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sterility Indicators Market Size Forecast by Type
11.6.1 Chemical Indicators
11.6.2 Biological Indicators
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sterility Indicators Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Pharmaceutical Companies
11.10.3 Medical Device Companies
11.10.4 Clinical laboratories
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sterility Indicators Analysis and Forecast
12.1 Introduction
12.2 Latin America Sterility Indicators Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sterility Indicators Market Size Forecast by Type
12.6.1 Chemical Indicators
12.6.2 Biological Indicators
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sterility Indicators Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Pharmaceutical Companies
12.10.3 Medical Device Companies
12.10.4 Clinical laboratories
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sterility Indicators Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sterility Indicators Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sterility Indicators Market Size Forecast by Type
13.6.1 Chemical Indicators
13.6.2 Biological Indicators
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sterility Indicators Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Pharmaceutical Companies
13.10.3 Medical Device Companies
13.10.4 Clinical laboratories
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sterility Indicators Market: Competitive Dashboard
14.2 Global Sterility Indicators Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 3M Company
14.3.2 Anderson Products Inc
14.3.3 Cantel Medical Corporation
14.3.4 Cardinal Health Inc
14.3.5 Getinge AB
14.3.6 Matachana Group
14.3.7 Mesa Laboratories
14.3.8 3M Company
